Olema exchanges ~6.07M shares for pre-funded warrants with Bain, Paradigm, BVF

Olema Pharmaceuticals, Inc.

Entered exchange agreements to swap 6,070,000 common shares for pre-funded warrants at $0.0001 exercise price.
Exchange expected to close Jan 13, 2025; post-close outstanding shares estimated at 68,333,065.
Warrants exercisable immediately; beneficial ownership capped at 9.99% (can be raised to 19.99% with notice).
Issuance exempt from registration under Securities Act Section 3(a)(9); not a registered offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.